{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:38:02Z","timestamp":1790534282238,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ijrobp.2019.04.031","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T08:03:40Z","timestamp":1557302620000},"page":"1141-1152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Preventing Radiation-Induced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel"],"prefix":"10.1016","volume":"104","author":[{"given":"C\u00e9line","family":"Cl\u00e9menson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winchygn","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Bricout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Soyez-Herkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Mondini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Wang-Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Benel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2019.04.031_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fonc.2017.00089","article-title":"Radiation-induced oral mucositis","volume":"7","author":"Maria","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib2","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1634\/theoncologist.2008-0024","article-title":"Radiation treatment breaks and ulcerative mucositis in head and neck cancer","volume":"13","author":"Russo","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib3","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1002\/cam4.1221","article-title":"Common oral complications of head and neck cancer radiation therapy: Mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis","volume":"6","author":"Sroussi","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.canrad.2017.11.006","article-title":"Pharmacological modulation of radiation-induced oral mucosal complications","volume":"22","author":"Bockel","year":"2018","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2016.04.001","article-title":"Management of chemo\/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature","volume":"120","author":"Moslemi","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijrobp.2014.09.022","article-title":"Prospective evaluation of severe skin toxicity and pain during postmastectomy radiation therapy","volume":"91","author":"Pignol","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaad.2005.08.054","article-title":"Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006","volume":"54","author":"Hymes","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib8","first-page":"313","article-title":"Acute radiation dermatitis in breast cancer patients: Challenges and solutions","volume":"9","author":"Kole","year":"2017","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1634\/theoncologist.2009-S104","article-title":"Radioprotectors and mitigators of radiation-induced normal tissue injury","volume":"15","author":"Citrin","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095968","article-title":"Effect of amifostine in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis based on randomized controlled trials","volume":"9","author":"Gu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib11","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2217\/fon.14.175","article-title":"Radioprotective agents for radiation therapy: Future trends","volume":"10","author":"Johnke","year":"2014","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib12","first-page":"331","article-title":"Differential chemoprotection of normal and malignant tissues","volume":"42","author":"Yuhas","year":"1969","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.radonc.2003.10.005","article-title":"Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients","volume":"70","author":"Rades","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1634\/theoncologist.12-6-738","article-title":"Amifostine: The first selective-target and broad-spectrum radioprotector","volume":"12","author":"Kouvaris","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ijrobp.2009.03.006","article-title":"Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection","volume":"74","author":"Mangoni","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0167-8140(83)80018-8","article-title":"A murine model of lip epidermal\/mucosal reactions to x-irradiation","volume":"1","author":"Parkins","year":"1983","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib17","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1158\/1535-7163.MCT-14-1015","article-title":"Synergy of radiotherapy and a cancer vaccine for the treatment of HPV-associated head and neck cancer","volume":"14","author":"Mondini","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib18","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00520-006-0047-4","article-title":"Amifostine in the management of radiation-induced and chemo-induced mucositis","volume":"14","author":"Bensadoun","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib20","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijrobp.2004.10.032","article-title":"Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure","volume":"61","author":"Cassatt","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2307\/3574479","article-title":"Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse1,2","volume":"68","author":"Utley","year":"1976","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2009.25.5638","article-title":"Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: Final results of the GORTEC2000-02 phase III randomized trial","volume":"29","author":"Bardet","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/jrr\/rru024","article-title":"Assessment of the effect of local application of amifostine on acute radiation-induced oral mucositis in guinea pigs","volume":"55","author":"Li","year":"2014","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000350396","article-title":"Feasibility study of the pharmacology of local application of amifostine (WR-2721) to the buccal mucosa in guinea pigs","volume":"91","author":"Li","year":"2013","journal-title":"Pharmacology"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00001813-200203000-00001","article-title":"Amifostine in clinical oncology: Current use and future applications","volume":"13","author":"Koukourakis","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib26","series-title":"Radiation Sensitizers","first-page":"303","article-title":"The role of WR-2721 in radiotherapy and\/or chemotherapy","author":"Yuhas","year":"1980"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib27","first-page":"3263","article-title":"Outcome of local application of amifostine (WR-1065) on epirubicin-induced oral mucositis. A phase II study","volume":"24","author":"Stokman","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib28","first-page":"339","article-title":"Applications of thermo-reversible pluronic f-127 gels in pharmaceutical formulations","volume":"9","author":"Escobar-Chavez","year":"2006","journal-title":"J\u00a0Pharm Pharm Sci"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.msec.2017.12.022","article-title":"An overview of polymeric dosage forms in buccal drug delivery: State of art, design of formulations and their in\u00a0vivo performance evaluation","volume":"86","author":"Fonseca-Santos","year":"2018","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40257-016-0186-4","article-title":"Radiodermatitis: A review of our current understanding","volume":"17","author":"Singh","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/CCO.0000000000000180","article-title":"Mucositis: Pathobiology and management","volume":"27","author":"Villa","year":"2015","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.seminoncol.2003.11.014","article-title":"Amifostine: Is there evidence of tumor protection?","volume":"30","author":"Koukourakis","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00520-016-3521-7","article-title":"Topical interventions to prevent acute radiation dermatitis in head and neck cancer patients: A systematic review","volume":"25","author":"Ferreira","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2217\/fon-2017-0359","article-title":"Prevention and treatment of radiation-induced acute dermatitis in head and neck cancer patients: A systematic review","volume":"14","author":"Iacovelli","year":"2018","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib35","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.2010.32.4103","article-title":"Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: A randomized, placebo-controlled trial","volume":"29","author":"Henke","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib36","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1200\/JCO.2010.32.4095","article-title":"Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: A randomized, placebo-controlled study","volume":"29","author":"Le","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/CCO.0000000000000452","article-title":"Photobiomodulation or low-level laser therapy in the management of cancer therapy-induced mucositis, dermatitis and lymphedema","volume":"30","author":"Bensadoun","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib38","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.tranon.2018.03.014","article-title":"A review of clinical radioprotection and chemoprotection for oral mucositis","volume":"11","author":"Oronsky","year":"2018","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijrobp.2017.10.019","article-title":"Phase 1b\/2a trial of the superoxide dismutase mimetic GC4419 to reduce chemoradiotherapy-induced oral mucositis in patients with oral cavity or oropharyngeal carcinoma","volume":"100","author":"Anderson","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.04.031_bib40","article-title":"Superoxide dismutase mimetic GC4419 enhances the oxidation of pharmacological ascorbate and its anticancer effects in an H2O2-dependent manner","volume":"7","author":"Heer","year":"2018","journal-title":"Antioxidants (Basel)"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619306935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619306935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T11:42:56Z","timestamp":1663414976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301619306935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0360301619306935"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.04.031","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing Radiation-Induced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}